The world's leading medical device manufacturer and trade platform
Founded in 1883, heyer Medical AG has extensive international influence in the fields of aerosol inhalation, oxygen therapy, anesthesia machine, and ventilator.
In order to expand the international market, the heyer international marketing platform has been formed through commercial collaboration to provide our customers with a full range of medical solutions.
Today, the heyer Group encompasses the medical care, health, and biotechnology sectors, with a comprehensive product portfolio covering anesthesia machines, ventilators, sleep apnea devices, oxygen therapy equipment, emergency care & first aid solutions, and self-testing products
Executive Team
Development Milestone
Honors&Qualifications
heyer Medical AG & Baden-Baden Gold Medal: A Legacy of
Respiratory Innovation

In the early 1900s, famous contemporaries, like the Czar of Russia, Kings of Belgium and Norway came to Bad Ems to join the heyer inhalation therapy.
In 1982, launched heyer's fully modular anesthesia systems with integrated ventilator based on latest quality and safety standards.
Revolutionized pulmonary drug delivery with micron-level precision, laying foundations for modern inhalation therapies.
heyer: A Century of Respiratory Guardianship

Since 1902, heyer Medical AG has been serving European royalty with precise respiratory care. Czar Nicholas II found relief from asthma through heyer's oxygen therapy in Bad Ems, earning widespread acclaim among monarchs, including Norway's King Haakon VII and Belgium's King Leopold II, who commissioned custom gold-plated nebulizers.
During the 1918 influenza pandemic, heyer donated 200 emergency nebulizers to royal households. Over a century later, amidst the COVID-19 pandemic, the company delivered 50,000 ICU ventilators globally within 18 months, demonstrating its rapid response and production capabilities.
During the COVID-19 pandemic in 2020, heyer Medical AG maintained an impeccable safety record with zero COVID-19 infections among its production staff while fulfilling global demand. Despite severe supply chain disruptions, the company achieved a 99.3% on-time delivery rate for ventilators, delivering 50,000 units worldwide. This achievement not only highlighted heyer's exceptional manufacturing prowess but also underscored its profound sense of responsibility to global health. As a company with a 120-year legacy, heyer remains committed to its mission of relentless efforts in advancing human health. Through unparalleled technological innovation and unwavering humanitarian commitment, heyer continues to play a vital role in safeguarding lives and enhancing healthcare standards worldwide.
Carl-heyer-Straße
Industry Status
ESG Report
Social Responsibility Report
We use cookies to enhance your browsing experience, serve personalized ads or content and analyze our traffic. By clicking "Accept." you consent to our use of cookies.Further information may be found in our Privacy Policy.